Willie Muehlhausen

Digital Innovator, Partner
SAFIRA Clinical Research, Ireland
Willie Co-founded SAFIRA 2021 after spending more than 20 years in the clinical research industry working for CROs and technology companies in Germany, the UK, US and Ireland. He served as the inaugural Vice-Director of the C-Path ePRO Consortium shaping the initial work of the founding members and is an active member in DIA, ISPOR and DIME research groups. In recent years he initiated and directed research on multiple patient-facing technologies (i.e. ePRO / BYOD, Wearables, Patient Burden, Fraud Detection via Machine Learning) and co-authored more than 40 publications and two books on electronic Patient-Reported Outcomes. Willie successfully developed multiple product and service lines in the eCOA space including the first dedicated ePRO Management group within a global CRO. His work has been recognized by his industry peers by including him in the PharmaVoice100 in 2015 and the CenterWatch Top 20 Innovators in 2018.

Events/Masterclasses Willie Muehlhausen is currently speaking at

Pharma

Digital Quality in Clinical Trials
28 - 29 November 2023
NH Amsterdam Caransa, Amsterdam, Netherlands
This unique course provides a practical & in-depth understanding of electronic systems and technologies used in clinical trials, and brings clarifications on global regulation, requirements, compliance & quality concerns.

Are you interested in a custom-made event with this trainer?

Contact us to Request more information about your custom-made Corporate Learning program.

REQUEST MORE INFORMATION

Willie Muehlhausen
Digital Innovator, Partner
SAFIRA Clinical Research, Ireland
Willie Co-founded SAFIRA 2021 after spending more than 20 years in the clinical research industry working for CROs and technology companies in Germany, the UK, US and Ireland. He served as the inaugural Vice-Director of the C-Path ePRO Consortium shaping the initial work of the founding members and is an active member in DIA, ISPOR and DIME research groups. In recent years he initiated and directed research on multiple patient-facing technologies (i.e. ePRO / BYOD, Wearables, Patient Burden, Fraud Detection via Machine Learning) and co-authored more than 40 publications and two books on electronic Patient-Reported Outcomes. Willie successfully developed multiple product and service lines in the eCOA space including the first dedicated ePRO Management group within a global CRO. His work has been recognized by his industry peers by including him in the PharmaVoice100 in 2015 and the CenterWatch Top 20 Innovators in 2018.
Willie Muehlhausen
Description